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Abstract
Aim: To explore the current central venous dialysis catheter (CVDC) nursing 
care practices in Australia. Method: A survey of dialysis units in Australia. Results: 
66% return rate (48/73) Internal jugular is the main insertion site (75%) and 
the majority are tunneled (85%). Insertion was performed most commonly 
by radiologists (34%) followed by intensivists (24%) with one center reporting 
insertion by nursing staff. CVDCs were most commonly inserted in radiology 
(54%), followed by theatre (33%). Dressings were attended weekly (55%) or 
on dialysis days (45%). Chlorhexidine was the antiseptic solution of choice 
(54%) followed by povidine-iodine (37%). In 21% of centres Mupirocin was 
routinely applied in addition to the antiseptic solution. Transparent dressings were 
overwhelmingly favoured however most centres recommended alternatives related 
to patient need. 21% of units reported enrolled nurses undertaking dressings. All 
units reported the use of sterile gloves and sterile dressing packs. 10% reported 
different routine care for tunneled and non-tunneled. 40% of the units collected 
data on infection rates per catheter days. General opinion (39%) was identifi ed 
as the reason to base CVDC protocols while descriptive studies (25%), RCTs 
(23%) and guidelines (18%) were also reported. Conclusion: There are signifi cant 
variations in the Australian nursing practice related to the care of CVDCs. 
Although there is still practice based on general opinion there is evidence that 
changes in practice in the past 8 years may be associated with knowledge derived 
from research. 
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Introduction
In Australia 10% of all patients requiring 
haemodialysis dialyse via central venous 
dialysis catheters (CVDCs). In addition, 
58% of all haemodialysis patients dialyze 
via a CVDC on their fi rst dialysis 
treatment (ANZDATA, 2005). In 
Australia, patients with a CVDC at the 
commencement of dialysis have a two 
to threefold increase in the risk of death 
complications. Following the insertion of 
the CVDC it is the nurse who practices 
connection/disconnection procedures 
and insertion site dressing procedures. A 
survey of Australian haemodialysis access 
practices, undertaken in by Bolch (1998), 
confi rmed that variations in care exist 
among dialysis centres in Australia. This 
was consistent with US nursing literature 
(Thomas-Hawkins, 1996). The authors 
were concerned with the variation of 
practice and the potential that units 
were not using the latest evidence in 
practice. Thus, the aim of this study was 
to identify current CVDC nursing care 
practices in Australia in 2005 and identify 
the basis for nursing related decisions in 
CVDC care. 
Methods
An initial test pilot survey was sent to 8 
random haemodialysis units in Australia. 
Feedback from this pilot survey was used 
to design the fi nal questionnaire. 
Sample
The survey was sent to all Australian 
tertiary haemodialysis units and all 
haemodialysis units not affi liated with a 
tertiary unit. The units were sourced from 
compared with the arterio-venous fi stula 
(Polkinghorne, McDonald, Atkins, & 
Kerr, 2004) and the most prominent and 
serious complication with CVDCs is 
infection (Schwab & Beathard, 1999).
CVDC infection can be classifi ed as exit 
site infection, tunneled infection and 
catheter-related bacteraemia (Schwab 
& Beathard, 1999). Nursing staff play an 
essential role to prevent these infectious 
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the Kidney Health Australia Database 
of Australian Dialysis Units at March, 
2005 (Kidney Health Australia, 2005). 
The survey, including an introductory 
letter, was mailed to Nurse Managers 
(also known as Clinical Nurse Managers, 
Nurse Unit Managers and Clinical 
Nurse Consultants). Pre-stamped and 
addressed return envelopes were provided 
and the returned surveys were opened 
by a third party to assure anonymity of 
data. There were no questions included 
that would identify the responding 
units, therefore responses could not be 
linked to a particular unit. Participants 
were informed that completing the 
survey would serve as their consent to 
participate in the survey. 
There were limitations to the sampling 
in this study. Firstly, the questionnaires 
were addressed to the Nurse Manager 
of each dialysis unit. Thus, the authors 
have made the assumption that the Nurse 
Manager was in the best position to 
accurately report the current practice of 
the dialysis unit. Anonymity assurance 
was a feature of this survey. We believed 
that this would increase the accuracy and 
“truth” of the responses. However, the 
downside to this was that the reduced 
potential to clarify unclear responses, 
exploring responses further and extract 
further information from the units. The 
authors acknowledge that to protect 
anonymity there was limited questioning 
on the characteristics of the unit. Details 
relating to unit size, location, patient age, 
patient numbers, staff characteristics etc. 
would have potentially identifi ed the unit 
and decreased anonymity. In addition the 
issue of anonymity reduced the potential 
response rate and did not allow for follow 
up and reminder correspondence. 
Data Collection Instrument
The questionnaire consisted of 18 
major questions. Nine sub-questions 
were added to explore several aspects 
further. A funnel approach was adopted 
commencing with broad questions 
followed by more specifi c questions. 
Closed or forced questions were used as 
many of the choices were already known 
as a result of the pilot study and suitable 
pre-determined response codes had been 
developed (Bowling, 1997). In addition, 
the survey included open or follow-up 
questions for clarifi cation and further 
detail (Minichiello, Sullivan, Greenwood, 
& Axford, 1999). 
Issues related to face validity or “the 
extent to which the research tool 
measures what it is supposed to measure” 
(Clifford, 1997, p. 35) were addressed 
through feedback from the pilot study. 
Results from the pilot study were 
presented to the participating units who 
considered the instrument was measuring 
clinically signifi cant areas in relation to 
CVDC nursing care. 
Following the pilot study the 
questionnaire was designed to address 
several aspects relating to CVDC care. 
The questions addressed the following 
domains:
• CVDC insertion characteristics
• CVDC nursing care practice
• CVDC infection rate recording 
• Basis for procedure and protocol 
decision making 
Information relating to CVDC 
insertion characteristics were sought. 
This information consisted of Insertion 
method, type of catheter (tunneled or 
non-tunneled), which member of staff 
was responsible for the insertion and in 
what part of the hospital the insertions 
were undertaken. 
Information about the nursing policies 
and procedures relating to frequency, 
personnel, solutions used, dressing 
material used, intravenous medication 
usage, where the dressing was performed, 
and antibiotic prophylaxis information 
were sought. Infection rate information 
was sought in addition to information 
relating to what basis (RCTs, general 
opinion etc.) the units based their 
policies and procedures on.
Data Analysis
The data was manually coded and 
verifi ed by a second independent 
researcher. Question response frequencies 
were calculated. In addition, narrative 
comments were recorded to assist further 
analysis of the data. 
Ethics
Ethics approval for this survey was 
received from the originating health 
service organisation. The health service 
is a community based hospital with a 
focus towards primary health care. No 
fi nancial incentives were provided and no 
coercion was undertaken. Respondents 
all participated voluntarily. The research 
was not fi nancially supported, sponsored 
or infl uenced by any external party.
Limitations
No statistical analysis was performed on 
the data. This was deemed as appropriate 
by the authors as the survey responses 
were to provide a descriptive overview of 
current CVDC practices and encourage 
debate and discussion relating to best 
practice CVDC care in Australia. 
The length of the questionnaire has 
varying effects on response rates. Thus, 
further information on CVDC care 
including connection procedures, 
percentage of CVDCs, infection 
rate measurement details and unit 
characteristics was not included as there 
was a limit on how many questions the 
respondents would reply to. As Sarantakos 
suggests “one should include as many 
questions as necessary and as few as 
possible” (1998, p. 228). 
Results
Of the 73 questionnaires mailed to 
Clinical Nurse Managers 48 were 
returned completed and 2 were returned 
to sender. This represents a response rate 
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of 66% (48/73). This represented 33 
tertiary hospitals (69%), 15 satellite units 
(31%) and 4 home training units (8%). 
Some units considered themselves both 
tertiary hospitals and home dialysis units. 
The results are summarised in Tables 1 
to 4.
The majority of units performed CVDC 
dressings weekly (55%) while 45% of 
units performed them each dialysis. 
Units noted that it was dependent 
on the dressing whether occlusive or 
non-occlusive, that the dressing may 
be changed daily if the patient was 
an inpatient or that it was “changed 
if soiled”. One unit reported that the 
dressings were performed on dialysis 
days for the fi rst month and then twice 
weekly.
The antiseptics solutions applied to the 
insertion site were chlorhexidine (54%) 
followed by povidine-iodine (37%). A 
small amount of units used chlorhexidine 
and alcohol mix (10%) while 1 unit 
reported the use of chlorhexidine 
followed by the application of 
MedihoneyTM to the insertion site 
and another was trialing this. One unit 
reported the use of triclosan 1% in 
normal saline followed by mupirocin. 
One unit reported the use of hydrogen 
peroxide. Twenty one percent applied 
mupirocin following the antiseptic. 
Those applying Mupirocin either used 
chlorhexidine, povidine-iodine or 
triclosan. Several units reported that they 
had recently introduced a chlorhexidine 
gluconate impregnated dressing called 
the Biopatch™. One unit reported the 
use of mupirocin for the fi rst month only 
whilst another unit specifi ed the use of 
mupirocin for the fi rst two weeks until 
the tunnel has “healed”. Ten percent of 
units reported the use of prophylactic 
antibiotics. The favoured prophylaxis was 
mupirocin applied to the nasal passages 
particularly if patients were positive for 
staphylococcus aureus. Further details of 
Mupirocin use were not obtained.
Discussion
CVDC Insertion Practices
Although CVDC insertion practices 
were not the primary aim of this survey 
the researchers felt that this information 
was of interest to Australian nurses. The 
fi nding that 75% of respondents reported 
the internal jugular vein (IJV) as the 
main site for insertion and that femoral 
sites being used for temporary use only 
are consistent with CARI Guideline 
16 (CARI, 2000). This is a signifi cant 
increase from 21% IJV reported in 1998 
(Bolch). 
CARI recommends that CVDC 
insertion should be performed by, or 
under the supervision of experienced 
personnel, in sterile conditions and 
under direct vision, either surgical or 
ultrasound-guided. Our fi ndings confi rm 
that these recommendations are being 
followed in Australian haemodialysis 
units. Of note in our results is the 
reported insertion of CVDCs by a nurse. 
We believe that this is the fi rst report 
in the literature of an Australian nurse 
inserting CVDCs. 
CVDC Nursing Care Practices
The past 8 years have seen an increase 
in dialysis centre’s preference for 
tunneled over non-tunneled catheters. 
The reported increase has been from 
25% (Bolch, 1998) to our reported 
85% in 2005. However, with the few 
exceptions the increase in tunneled 
catheter use has seen little change in 
the nursing practices of these catheters. 
Although, several centres report different 
practices only 10 % of units reported 
different routine care for tunneled 
and non-tunneled catheters. Several 
centres reported that non-tunneled 
catheter insertion sites were dressed and 
inspected more frequently than tunneled 
catheters. One centre reported that after 
two weeks no dressings were applied 
to tunneled insertion sites and several 
centres reported that patients can shower 
after 6 weeks of insertion of tunneled 
catheter. Several centres reported the use 
of gauze 3 months following insertion 
for tunneled catheters. Unfortunately no 
further information on outcomes related 
to these various practices was reported. 
With the increase in tunneled catheters 
used for haemodialysis in Australia this is 
a very exciting area for further nursing 
research.
Central Venous Dialysis Catheter Care: An Australian Survey
Insertion 
Site
Internal jugular 
75% (36)
Subclavian    
23%(11)    
No Response   
2% (1)
Tunneling Practice Tunneled   
85% (41)
Non-Tunneled
13% (6)
Equal      
2% (1)
Medications inserted Yes 
30% (14)
No
70% (34)
CVDC 
Inserters*
Radiologist
34% (24)
Intensivist
24% (17)
Renal Registrar 
21% (15)
Surgeon
15% (11)
Nephrologist
6% (4)
Nurse
2% (1)
Place of Insertion* Radiology
54% (26)
Theatre
33% (16)
ICU
18% (9)
Ward Tx Rm
10% (5)
Dialysis Rm
8% (4)
Table 1. CVDC Insertion Characteristics. (* More than one response accepted)
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Australian clinical practice guidelines 
(CARI) are restricted by the lack of 
reported strong evidence. They list 
practice tips for central line catheter 
care but this is in the absence of Level 
1 evidence. The guidelines recommend 
the catheter should be covered by a 
dressing however the optimum dressing 
and frequency of change are undefi ned. 
In addition, the catheter should be 
inspected for signs of infection and 
dressing performed at each dialysis 
treatment. A meta analysis of a number 
of small studies suggested that there 
was no evidence of any difference in 
the incidence of infection between 
gauze and tape dressings and transparent 
polyurethane dressings for central 
venous catheters (Gillies et al., 2003). 
Conclusions by the authors indicated that 
the type of dressing could therefore be 
based on patient preference. There was 
no distinction made between tunneled 
or non-tunneled catheters in any of the 
included studies and so the application 
of this meta analysis may need to be 
used with caution when applying it 
specifi cally to tunneled haemodialysis 
catheters. In Gillies’ meta analysis of the 
six included studies only 2 compared 
Opsite IV3000 TM with gauze and tape, 
with two comparing Opsite TM with 
Opsite IV 3000 TM and one with gauze 
and tape and Tegaderm TM and one with 
Tegaderm TM and Opsite TM (Gillies 
et al., 2003). In addition transparent 
dressings such as Opsite IV3000 TM 
that increase the rate of evaporation of 
fl uid from the site compared with other 
transparent dressings may decrease risk of 
infection. (Gillies et al., 2003) Therefore, 
the type of transparent dressing used may 
infl uence infection outcomes. It could 
therefore be argued that the type of 
catheter dressing will be infl uenced by 
patient cohort and dressing type should 
be based on unit infection rates, need for 
catheter security and patient tolerance to 
dressing material. This is refl ected in the 
current use of transparent dressings of 
Opsite IV3000 TM and Tegaderm TM in 
Australia. Our results found the antiseptic 
solution of choice applied to the 
insertion site was chlorhexidine (54%) 
followed by povidine-iodine (37%). The 
authors wish to acknowledge that the 
strength of chlorhexidine solution was 
not considered in the survey. This can be 
viewed as a weakness in this study. 
There has been an increase in the use 
of chlorhexidine and a decrease in the 
use of povidine-iodine in the past 8 
years when compared to a previous 
survey (Bolch, 1998). The issue of 
alcohol degrading the catheters was a 
concern and the emergence of non-
alcohol based chlorhexidine has possibly 
contributed to its increased use. A 
systematic review of chlorhexidine 
gluconate vs. povidine-iodine relating to 
catheter related bloodstream infection 
outcome favoured chlorhexidine 
gluconate (Chaiyakunapruk, Veenstra, 
Lipsky, & Saint, 2002). However, to relate 
this review to tunneled haemodialysis 
catheters requires caution. Reports of 
catheter degradation have resulted in 
some catheter manufacturers warning 
against the use glycol ointments over 
catheter sites due to the potential for 
catheter degradation (Bolch, 1998; 
KDOQI, 2000). 
There is clear evidence based on 
randomised controlled trials (RCTs) 
that the use of mupirocin at the catheter 
exit sit does reduce the risk of catheter 
related infections (CARI, 2000). KDOQI 
recommends the use of mupirocin 
ointment after catheter placement 
and at the end of each dialysis session 
(KDOQI, 2000). Twenty one percent 
of units applied mupirocin following 
cleaning of the site. Several units reported 
that they had recently introduced a 
chlorhexidine gluconate impregnated 
dressing (Biopatch™). Several well-
designed RCTs have demonstrated the 
effectiveness of mupirocin on catheter 
colonisation, exit site infection and 
bacteraemia in haemodialysis patients. 
One study concluded thrice weekly use 
of mupirocin in this catheter type resulted 
in a marked reduction in line related 
sepsis and improved catheter survival 
(D Johnson et al., 2002). Further work 
by this Australian group has suggested 
the potential for MedihoneyTM for the 
prevention of catheter related infections 
(Johnson et al., 2005). Although the 
authors acknowledge that this study 
was not adequately powered to assess 
therapeutic equivalence they concluded 
that the application of standardized 
antibacterial honey thrice weekly was 
safe, cheap, and effective and resulted in 
comparable rates of catheter-associated 
Frequency* Weekly
56% (27)
Dialysis Days
46% (21)
Other
23% (11)
Antiseptic 
Solution*
Chlorhex 
54% (26)
Pov/Iodine
37% (18)
Chlor/Alc 
10% (5)
Mupirocin 
21% (10)  
Medihoney 
4% (2)
Triclosan  
2% (1)
Dressing
Type*
OpSite 
50% (24)
Tegaderm
31% (15)
Not Stated
19% (9)
Other
21% (10)
Who * Registered Nurses
100% (48)
Enrolled Nurses
21% (10)
Other 
8 (17%)
RN Only
79% (38)
When Pre-Dialysis
65% (31)
Post Dialysis
19% (19)
Intradialytically/Anytime
16% (8)
Where Dialysis Room
94% (45)
Ward Tx Room
4% (2)
Other 
2% (1)
What* Sterile Packs 
100% (48)
Sterile Gloves
100% (48)
Mask 
11% (5)
Gown
0% (0)
Sterile Drape
35 (17)
Do you have different practices for 
Tunnelled and Non-tunnelled CVDCs?
Yes
11% (5)
No
89% (43)
Cover Patient’s 
Face*
No Mask
98% (47)
Sterile Drape  
8% (4)
Turn Away
7% (3)
Mask
2% (1)
Central Venous Dialysis Catheter Care: An Australian Survey
Table 2. CVDC Nursing Practice (* More than one response accepted)
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infection to mupirocin. The application 
of MedihoneyTM is an exciting option 
in our current environment of antibiotic 
resistance and an area for further research.
Although not specifi cally addressed in 
CARI guidelines KDOQI recommend 
the patient and staff wear a mask or 
face shield for the dialysis staff for all 
catheter dressing changes. Although all 
units reported the use of sterile gloves 
and sterile dressing packs to perform the 
CVDC dressing, only 10% reported the 
use of surgical masks by nurses and only 
2% (one unit) reported patients wearing 
a mask during the dressing. Several units 
reported that patients are asked to turn 
their heads away during the dressing 
procedure. This is an area that the authors 
feel requires more research given the 
increased use of tunneled CVDCs. 
The United States KDOQI guidelines 
(KDOQI, 2000) recommend dressing 
changes and catheter manipulation 
be performed by trained dialysis staff 
(evidence/opinion). Our fi ndings 
show 79% of units reported that only 
Registered Nurses (RNs) perform 
CVDC dressings. 2 (2/48) units 
added that only “Renal Trained” RNs 
performed dressings. However, the 
defi nition of “renal trained” was not 
required and not specifi ed and could be 
variously defi ned as external, tertiary 
renal/nephrology qualifi cations or local 
in-house training/education courses.
It was not within the scope of this survey 
to report the clinically signifi cant results 
of interventions, policies and procedures 
related to CVDC care. However, the 
authors felt it important to report policies 
that may be signifi cant to clinicians. 
These included the use of antibiotic 
catheter locks, luer access connection 
systems, weekly blood cultures and the 
use of “sandwich” dressings. 
CVDC Infection Rate Recording
Although the treatment of exit site 
infection, tunnel infection and catheter 
related bacteraemia may vary the prevention 
of all three is related to the nursing care 
provided. Thus, it was encouraging to 
report that 40% of units reported collecting 
infection rate data (given that 31% of 
surveyed centres described themselves as 
satellite units). These centres specifi cally 
reported collecting and analyzing central 
line infection rates by 100 or 1000 catheter 
days. 
CARI recommend that in the absence 
of clear evidence relating to the nursing 
care of haemodialysis CVDC infection 
rates should be recorded and audited 
(CARI, 2000). Although there are no 
mandated reporting mechanisms for 
recording of haemodialysis central line 
infection rates in Australian dialysis 
units the major Australian accreditation 
body, the Australian Council on 
Healthcare Standards (ACHS) introduced 
haemodialysis associated blood stream 
infection clinical indicators in 2004 as 
part of their infection control indicators. 
These indicators are stratifi ed by access 
type and include haemodialysis centrally 
inserted non-cuffed and cuffed dialysis 
line associated blood stream infection 
rate (Australian Council on Healthcare 
Standards, 2004). The denominator used 
may be expressed per 100 patient months 
or 1000 catheter days. 1000 catheter days 
has been utilized predominantly due 
to the relatively short length of time a 
CVDC is in place compared to a native 
access. KDOQI guidelines recommend 
target tunneled cuffed catheter systemic 
infection rates less than 10% at 3 months 
and less than 50% at 1 year. Irrespective 
of how units choose to express infection 
rates it is important that surveillance 
techniques are established and 
implemented to validate unit outcomes 
and provide a system for continuous 
quality improvement. 
Basis For Procedure and 
Protocol Decision Making
Nurses frequently lament the lack of 
evidence to support nursing practice. 
CVDC care is no exception. Although 
there are limited studies to base practice 
on it was encouraging that units reported 
clinical decision making based on 
RCTs (23%) and guidelines (18%). Two 
examples of these have been reported 
in this study. Firstly, the increase use of 
chlorhexidine over povidine-iodine as 
the antiseptic solution of choice. This 
trend may have been associated with the 
literature summarized in a meta-analysis 
that supports the use of chlorhexidine 
(Chaiyakunapruk, Veenstra, Lipsky, & 
Saint, 2002). Secondly, the increase in 
infection rate data collection from 20% 
to 40% may have an association with the 
recommendations of CARI and KDOQI 
guidelines. From the units (n=14) who 
reported changing their protocol as a 
result of infection rates only 2 units 
specifi ed the change. These were changes 
from a sandwich to a fl at dressing 
design and from Opsite 3000TM to 
Central Venous Dialysis Catheter Care: An Australian Survey
Table 3. Infection Rates
Do you collect CVDC infection 
rate data?
Yes
40% (19)
No
38% (18)
No response
22% (11)
What measurements do you use? 1000 Catheter days
52% (10/19)
100 Catheter days
48% (9/19)
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PrimaporeTM.
Although RCTs and guidelines have 
been utilized units still reported general 
opinion and descriptive studies as their 
basis for decision making. In addition, 
units reported that clinical protocols 
being based upon infection control units, 
intensive care policies, oncology practices, 
statewide consensus, manufacturer’s 
guidelines, a previous nationwide survey 
and several commented that their 
protocols were based on a combination 
of these sources. The wide variety of 
sources for decision making strengthens 
the argument for more research in the 
area of CVDC care.
Conclusions
There are variations in the Australian 
nursing practice related to the care of 
CVDCs. Although there is still practice 
based on general opinion our study 
has shown evidence that changes in 
practice in the past 8 years may be 
associated with knowledge derived from 
research. However, signifi cant diversity 
of current practice and limited numbers 
of published studies identify the need for 
RCTs of interventions in CVDC care. 
These are particularly required given the 
increase in tunneled catheters in Australia 
in the past 8 years. In addition, although 
there has been an increase in CVDC 
infection monitoring, the development 
of monitoring systems should be 
implemented further to observe the 
clinical outcomes and benefi ts of 
implementing CVDC practices.
Table 5. Comparisons of Australian Surveys 1998 and 2005
Bolch (1998) Bennett et al 
(2005)
% Tunneled cuffed catheter 25% 85%
% Subclavian vein access 64% 23%
% Chlorhexidine (without alcohol) on 
insertion site
12% 54%
% Povidine-iodine on insertion site 72% 37%
% Collect infection rates 20% 40%
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